BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 11337927)

  • 1. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K; Kimura K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Nemoto T; Yamanaka O; Yoshii Y; Tochikubo O; Umemura S
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of thrombolytic therapy and direct percutaneous transluminal coronary angioplasty for acute myocardial infarction: prospective multicenter trial at 16 clinical centers in Ibaraki prefecture TUGMI. Tsukuba University Group for Myocardial Infarction].
    Noguchi Y; Yamaguchi I; Sugishita Y
    J Cardiol; 1996 Mar; 27(3):111-20. PubMed ID: 8865683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of left ventricular aneurysm formation and left ventricular remodeling caused by percutaneous transluminal coronary angioplasty performed 24-48 hours after onset of acute myocardial infarction].
    Kanamasa K; Ogawa I; Koka H; Ishida N; Sasaki T; Nakabayashi T; Nakagawa K; Takada K; Kato H; Otani N; Ishikawa K; Katori R
    J Cardiol; 1996 Oct; 28(4):199-205. PubMed ID: 8934335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
    Kurihara H; Matsumoto S; Tamura R; Yachiku K; Nakata A; Nakagawa T; Yoshino T; Matsuyama T
    Am Heart J; 2004 Apr; 147(4):E14. PubMed ID: 15077097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of intracoronary thrombolysis versus percutaneous transluminal coronary angioplasty for treating acute myocardial infarction].
    Nakamura M; Yamaguchi T; Isshiki T; Nagahara T; Itaoka Y; Saeki F
    J Cardiol; 1992; 22(4):607-16. PubMed ID: 1343626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous transluminal coronary angioplasty for treatment of acute myocardial infarction: comparison with percutaneous transluminal coronary recanalization].
    Goto T; Mitsudo K; Matsunaga K; Doi O; Nishihara Y; Awa J; Hase T; Sakamoto T; Toda M; Kou E
    J Cardiol; 1989 Jun; 19(2):375-85. PubMed ID: 2636619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
    Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
    G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal reperfusion therapy in acute myocardial infarction: time to reperfusion and recanalization rate].
    Mochida Y; Kimura K; Kosuge M; Yoshida K; Iwasawa Y; Hongo Y; Sugiyama M; Ishikawa T; Kuji N; Tochikubo O; Ishii M
    J Cardiol; 1998 May; 31(5):255-62. PubMed ID: 9617655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction.
    Poloński L; Gasior M; Wasilewski J; Wilczek K; Wnek A; Adamowicz-Czoch E; Sikora J; Lekston A; Zebik T; Gierlotka M; Wojnar R; Szkodziński J; Kondys M; Szyguła-Jurkiewicz B; Wołk R; Zembala M
    Am Heart J; 2003 May; 145(5):855-61. PubMed ID: 12766744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct percutaneous transluminal coronary angioplasty (PTCA) for treatment of acute myocardial infarction: comparison with PTCA immediately after thrombolysis].
    Oka Y; Yoshida O; Kajiyama M; Masuoka T; Ito Y; Kawagoe T; Nagao H; Tsuchiya T
    J Cardiol; 1989 Jun; 19(2):365-73. PubMed ID: 2636618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.